Rutin forestalls dysregulated cardiac bioenergetics in bisphenol A and dibutyl phthalate-exposed rats through PPARα and AMPK modulation

Proper cardiac function is greatly dependent on adequate supply and metabolism of energy substrates. Environmental pollutants exposure including plasticizers can trigger adverse cardiac metabolic events. This study was designed to investigate the ameliorative effect of rutin (Rt) on dysregulated cardiac energy metabolism in plasticizer-exposed rats. Forty-two rats were randomised into seven groups (n = 6): Control (0.1% dimethyl sulfoxide), bisphenol A (BPA, 25 mg/kg, p.o), dibutyl phthalate (DBP, 25 mg/kg, p.o), BPA + Rt 25 mg/kg, Rt 50 mg/kg, DBP + Rt (25 mg/kg, Rt 50 mg/kg), BPA + DBP and BPA + DBP + Rt, daily for 21 days. BPA and DBP exposure increased plasma glucose, reduced insulin, and increased plasma and cardiac free fatty-acid. Cardiac glucose-6-phosphate level, hexokinase and pyruvate dehydrogenase activities increased in DBP while BPA reduced these variables. Cardiac glucose transporter-4 expression was reduced in BPA group, while cardiac peroxisome proliferator-activated receptor-alpha (PPARα) and AMP-activated protein kinase (AMPK) expression increased in BPA and DBP-treated rats. However, Rt administration prevents impaired cardiac bioenergetics and glucometabolic regulation. Summarily, Rt improves BPA and DBP-impaired cardiac bioenergetics through PPARα and AMPK modulation.

[1]  Yu-Tang Tung,et al.  Anti-NAFLD Effect of Djulis Hull and Its Major Compound, Rutin, in Mice with High-Fat Diet (HFD)-Induced Obesity , 2021, Antioxidants.

[2]  Kee K. Kim,et al.  Cardiac toxicity from bisphenol A exposure in human-induced pluripotent stem cell-derived cardiomyocytes. , 2021, Toxicology and applied pharmacology.

[3]  O. Michael,et al.  Rutin prevents cardiac oxidative stress and inflammation induced by bisphenol A and dibutyl phthalate exposure via NRF-2/NF-κB pathway. , 2021, Life sciences.

[4]  A. Zwolak,et al.  Heart Metabolism in Sepsis-Induced Cardiomyopathy—Unusual Metabolic Dysfunction of the Heart , 2021, International journal of environmental research and public health.

[5]  L. Bertrand,et al.  AMP-activated protein kinase: a remarkable contributor to preserve a healthy heart against ROS injury. , 2021, Free radical biology & medicine.

[6]  R. Singh,et al.  Plasticizers and Cardiovascular Health: Role of Adipose Tissue Dysfunction , 2021, Frontiers in Pharmacology.

[7]  C. Cheung,et al.  Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy , 2021, Cardiovascular Diabetology.

[8]  O. Michael,et al.  Cadmium exposure induces cardiac glucometabolic dysregulation and lipid accumulation independent of pyruvate dehydrogenase activity , 2021, Annals of medicine.

[9]  Chuan Dong,et al.  Disturbance of di-(2-ethylhexyl) phthalate in hepatic lipid metabolism in rats fed with high fat diet. , 2020, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[10]  Milena Anđelković,et al.  Multi-strain probiotic ameliorated toxic effects of phthalates and bisphenol A mixture in Wistar rats. , 2020, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[11]  Jun Ren,et al.  Double knockout of Akt2 and AMPK accentuates high fat diet-induced cardiac anomalies through a cGAS-STING-mediated mechanism. , 2020, Biochimica et biophysica acta. Molecular basis of disease.

[12]  A. Adedapo,et al.  Protective effects and chemical composition of Corchorus olitorius leaf fractions against isoproterenol-induced myocardial injury through p65NFkB-dependent anti-apoptotic pathway in rats , 2020, Journal of basic and clinical physiology and pharmacology.

[13]  M. Akash,et al.  Chronic exposure of bisphenol A impairs carbohydrate and lipid metabolism by altering corresponding enzymatic and metabolic pathways. , 2020, Environmental toxicology and pharmacology.

[14]  E. Moustafa,et al.  Boswellic acid protects against Bisphenol-A and gamma radiation induced hepatic steatosis and cardiac remodelling in rats: role of hepatic PPAR-α/P38 and cardiac Calcineurin-A/NFATc1/P38 pathways , 2020, Archives of physiology and biochemistry.

[15]  Jian-xing Ma,et al.  Distinct cardiac energy metabolism and oxidative stress adaptations between obese and non-obese type 2 diabetes mellitus , 2020, Theranostics.

[16]  I. Baranowska-Bosiacka,et al.  The influence of polyphenols on metabolic disorders caused by compounds released from plastics - Review. , 2020, Chemosphere.

[17]  Hui Teng,et al.  Sonchus oleraceus Linn extract enhanced glucose homeostasis through the AMPK/Akt/ GSK-3β signaling pathway in diabetic liver and HepG2 cell culture. , 2019, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[18]  Y. Zhang,et al.  Taxifolin alleviates apoptotic injury induced by DEHP exposure through cytochrome P450 homeostasis in chicken cardiomyocytes. , 2019, Ecotoxicology and environmental safety.

[19]  L. Alberici,et al.  Long-term exposure to bisphenol A or S promotes glucose intolerance and changes hepatic mitochondrial metabolism in male Wistar rats. , 2019, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[20]  O. Wever-Pinzon,et al.  DNA Methylation Reprograms Cardiac Metabolic Gene Expression in End-Stage Human Heart Failure. , 2019, American journal of physiology. Heart and circulatory physiology.

[21]  Jeong Hwan Park,et al.  Prognostic Implication of pAMPK Immunohistochemical Staining by Subcellular Location and Its Association with SMAD Protein Expression in Clear Cell Renal Cell Carcinoma , 2019, Cancers.

[22]  Y. Zhang,et al.  Taxifolin ameliorates DEHP-induced cardiomyocyte hypertrophy via attenuating mitochondrial dysfunction and glycometabolism disorder in chicken. , 2019, Environmental pollution.

[23]  Rick B. Vega,et al.  The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense. , 2019, JCI insight.

[24]  J. Griffin,et al.  Metabolic Profiling of the Diabetic Heart: Toward a Richer Picture , 2019, Front. Physiol..

[25]  Lei Wang,et al.  Association of urinary concentrations of bisphenols with type 2 diabetes mellitus: A case-control study. , 2018, Environmental pollution.

[26]  H. Abdel-Rahman,et al.  Lycopene: Hepatoprotective and Antioxidant Effects toward Bisphenol A-Induced Toxicity in Female Wistar Rats , 2018, Oxidative medicine and cellular longevity.

[27]  Z. Bouallagui,et al.  Oleuropein and hydroxytyrosol rich extracts from olive leaves attenuate liver injury and lipid metabolism disturbance in bisphenol A-treated rats. , 2018, Food & function.

[28]  Zheng Wen,et al.  Glucagon‐like peptide‐1 ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via the PPARα pathway , 2018, Aging cell.

[29]  H. Ren,et al.  Exogenous H2S switches cardiac energy substrate metabolism by regulating SIRT3 expression in db/db mice , 2018, Journal of Molecular Medicine.

[30]  M. Mendez,et al.  Urinary bisphenol A and obesity in adults: results from the Canadian Health Measures Survey. , 2017, Health promotion and chronic disease prevention in Canada : research, policy and practice.

[31]  L. Delbridge,et al.  Molecular mechanisms of cardiac pathology in diabetes - Experimental insights. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[32]  N. Milošević,et al.  The influence of phthalates and bisphenol A on the obesity development and glucose metabolism disorders , 2017, Endocrine.

[33]  S. Matoba,et al.  Activation of PPAR-α in the early stage of heart failure maintained myocardial function and energetics in pressure-overload heart failure. , 2017, American journal of physiology. Heart and circulatory physiology.

[34]  G. Lopaschuk,et al.  Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes. , 2016, Biochimica et biophysica acta.

[35]  Hai-Yan Xu,et al.  Bisphenol A Exposure May Induce Hepatic Lipid Accumulation via Reprogramming the DNA Methylation Patterns of Genes Involved in Lipid Metabolism , 2016, Scientific Reports.

[36]  C. Guerrero-Bosagna,et al.  Bisphenol-A and metabolic diseases: epigenetic, developmental and transgenerational basis , 2016, Environmental epigenetics.

[37]  J. Sowers,et al.  Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy , 2016, Nature Reviews Endocrinology.

[38]  Mark D. Huffman,et al.  Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association , 2016, Circulation.

[39]  R. Tian,et al.  Glucose Transporters in Cardiac Metabolism and Hypertrophy. , 2015, Comprehensive Physiology.

[40]  M. Shih,et al.  Possible Mechanisms of Di(2-ethylhexyl) Phthalate-Induced MMP-2 and MMP-9 Expression in A7r5 Rat Vascular Smooth Muscle Cells , 2015, International journal of molecular sciences.

[41]  Mak-Soon Lee,et al.  Rutin Increases Muscle Mitochondrial Biogenesis with AMPK Activation in High-Fat Diet-Induced Obese Rats , 2015, Nutrients.

[42]  Yong-Bin Wang,et al.  Rutin alleviates diabetic cardiomyopathy in a rat model of type 2 diabetes , 2014, Experimental and therapeutic medicine.

[43]  Pascal G. P. Martin,et al.  Adverse effects of long-term exposure to bisphenol A during adulthood leading to hyperglycaemia and hypercholesterolemia in mice. , 2014, Toxicology.

[44]  N. Posnack The Adverse Cardiac Effects of Di(2-ethylhexyl)phthalate and Bisphenol A , 2014, Cardiovascular Toxicology.

[45]  H. Jia,et al.  The metabolic disturbances of isoproterenol induced myocardial infarction in rats based on a tissue targeted metabonomics. , 2013, Molecular bioSystems.

[46]  K. Balasubramanian,et al.  Effect of bisphenol-A on insulin signal transduction and glucose oxidation in skeletal muscle of adult male albino rat , 2013, Human & experimental toxicology.

[47]  G. Lopaschuk,et al.  Pyridine nucleotide regulation of cardiac intermediary metabolism. , 2012, Circulation research.

[48]  Horng-mo Lee,et al.  Fenofibrate lowers lipid accumulation in myotubes by modulating the PPARα/AMPK/FoxO1/ATGL pathway. , 2012, Biochemical pharmacology.

[49]  N. Lee,et al.  Phthalate Exposure Changes the Metabolic Profile of Cardiac Muscle Cells , 2012, Environmental health perspectives.

[50]  P. Schulze,et al.  Lipid metabolism and toxicity in the heart. , 2012, Cell metabolism.

[51]  D. Melzer,et al.  Urinary Bisphenol A Concentration and Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women , 2012, Circulation.

[52]  T. Arumugam,et al.  Rutin attenuates metabolic changes, nonalcoholic steatohepatitis, and cardiovascular remodeling in high-carbohydrate, high-fat diet-fed rats. , 2011, The Journal of nutrition.

[53]  R. Tian,et al.  Glucose metabolism and cardiac hypertrophy. , 2011, Cardiovascular research.

[54]  D. da Silva,et al.  Metformin reverses hexokinase and 6-phosphofructo-1-kinase inhibition in skeletal muscle, liver and adipose tissues from streptozotocin-induced diabetic mouse. , 2010, Archives of biochemistry and biophysics.

[55]  R. Halden Plastics and health risks. , 2010, Annual review of public health.

[56]  Hyung Sik Kim,et al.  Comparison of the Short Term Toxicity of Phthalate Diesters and Monoesters in Sprague-Dawley Male Rats , 2010, Toxicological research.

[57]  Jeroen J. Bax,et al.  Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. , 2009, Journal of the American College of Cardiology.

[58]  Louis Hue,et al.  The Randle cycle revisited: a new head for an old hat. , 2009, American journal of physiology. Endocrinology and metabolism.

[59]  Marjan Nassiri-Asl,et al.  Effects of rutin on lipid profile in hypercholesterolaemic rats. , 2009, Basic & clinical pharmacology & toxicology.

[60]  P. S. M. Prince,et al.  Rutin improves glucose homeostasis in streptozotocin diabetic tissues by altering glycolytic and gluconeogenic enzymes , 2006, Journal of biochemical and molecular toxicology.

[61]  R. Cooksey,et al.  Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. , 2005, Endocrinology.

[62]  A. Szutowicz,et al.  Determination of pyruvate dehydrogenase and acetyl-CoA synthetase activities using citrate synthase. , 1981, Analytical biochemistry.

[63]  P. Trinder Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor , 1969 .

[64]  M. Parihar,et al.  Metabolic enzymes dysregulation in heart failure: the prospective therapy , 2016, Heart Failure Reviews.

[65]  K. Clarke,et al.  Myocardial substrate metabolism in heart disease. , 2012, Frontiers in bioscience.

[66]  C. Folmes,et al.  Myocardial fatty acid metabolism in health and disease. , 2010, Physiological reviews.

[67]  N. Kamalakkannan,et al.  Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic wistar rats. , 2006, Basic & clinical pharmacology & toxicology.

[68]  Xianlin Han,et al.  The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. , 2002, The Journal of clinical investigation.